Education
About Us
Working with TipRanks
Follow Us
Relay Therapeutics (RLAY)
NASDAQ:RLAY
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 15.36M | $ 10.01M | $ 25.55M | $ 1.38M | $ 3.03M |
| Gross Profit | $ 11.80M | $ 10.01M | $ 25.55M | $ 1.38M | $ 3.03M |
| Operating Income | $ -302.74M | $ -372.47M | $ -373.00M | $ -299.27M | $ -364.70M |
| EBITDA | $ -299.18M | $ -380.21M | $ -374.15M | $ -306.82M | $ -223.08M |
| Net Income | $ -276.48M | $ -337.71M | $ -341.97M | $ -290.51M | $ -363.87M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 84.02M | $ 781.32M | $ 750.09M | $ 998.92M | $ 958.07M |
| Total Assets | $ 621.33M | $ 871.30M | $ 843.98M | $ 1.10B | $ 1.01B |
| Total Debt | $ 32.46M | $ 48.50M | $ 53.47M | $ 57.74M | $ 22.90M |
| Net Debt | $ -51.56M | $ -75.78M | $ -90.27M | $ -941.17M | $ -257.22M |
| Total Liabilities | $ 54.27M | $ 93.50M | $ 91.98M | $ 149.55M | $ 110.64M |
| Stockholders' Equity | $ 567.06M | $ 777.79M | $ 752.00M | $ 950.22M | $ 897.81M |
| Cash Flow | |||||
| Free Cash Flow | $ -235.87M | $ -251.13M | $ -304.44M | $ -238.55M | $ -77.88M |
| Operating Cash Flow | $ -235.46M | $ -249.11M | $ -300.32M | $ -229.49M | $ -74.41M |
| Investing Cash Flow | $ 192.80M | $ -41.08M | $ 257.63M | $ -188.75M | $ -479.51M |
| Financing Cash Flow | $ 1.60M | $ 270.15M | $ 34.75M | $ 289.91M | $ 388.09M |